Finance And Related Services Tenders

Conclusion of a Non-Exclusive Discount Agreement in Accordance with § 130A Paragraph 8 Sgb V for the Ws Allergen Extract from House Dust Mites (Excluding Dosage Form Sublingual Tablets) for the Period October 1St, 2023 - September 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Paragraph 8 Sgb V for the Active Ingredient Colesevelam, Atc C10ac04 for the Period October 1St, 2023 - September 30Th, 2025

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Saso - Security Assessment and System Optimisation (ex-post)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to § 130A Paragraph 8 Sgb V (Open House Model)

Conclusion of a Non-Exclusive Framework Agreement for Investigations and Appraisals in the Open House Procedure of the West Branch

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Open House Discount Contracts 2023-10

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Follitropin Beta (G03ga06) as Part of a So-Called Open House Model.